Literature DB >> 12147253

Negative regulation of EphA2 receptor by Cbl.

You jie Wang1, Satoshi Ota, Hideki Kataoka, Masao Kanamori, Zhong you Li, Hamid Band, Masamitsu Tanaka, Haruhiko Sugimura.   

Abstract

The c-Cbl proto-oncogene product Cbl has emerged as a negative regulator of receptor and non-receptor tyrosine kinases, a function dependent on its recently identified ubiquitin ligase activity. Here, we report that EphA2, a member of Eph receptor tyrosine kinases is negatively regulated by Cbl. The negative regulation of EphA2 mediated by Cbl is dependent on the activity of EphA2, as the kinase inactive mutant of EphA2 cannot be regulated by Cbl. Moreover, a point mutation (G306E-Cbl) in TKB region of Cbl that has been reported to abolish Cbl binding to RTKs and non-receptor tyrosine kinases impaired the binding to active EphA2. The dominant negative mutant 70Z-Cbl, which has a 17-amino acids deletion in the N-boundary of the RING finger domain, defuncted negative regulatory function of Cbl to EphA2. These results demonstrate that the TKB domain and RING finger domain of Cbl are essential for this negative regulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147253     DOI: 10.1016/s0006-291x(02)00806-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.

Authors:  Joachim Lupberger; Mirjam B Zeisel; Fei Xiao; Christine Thumann; Isabel Fofana; Laetitia Zona; Christopher Davis; Christopher J Mee; Marine Turek; Sebastian Gorke; Cathy Royer; Benoit Fischer; Muhammad N Zahid; Dimitri Lavillette; Judith Fresquet; François-Loïc Cosset; S Michael Rothenberg; Thomas Pietschmann; Arvind H Patel; Patrick Pessaux; Michel Doffoël; Wolfgang Raffelsberger; Olivier Poch; Jane A McKeating; Laurent Brino; Thomas F Baumert
Journal:  Nat Med       Date:  2011-04-24       Impact factor: 53.440

2.  Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2.

Authors:  Masamitsu Tanaka; Riuko Ohashi; Ritsuko Nakamura; Kazuya Shinmura; Takaharu Kamo; Ryuichi Sakai; Haruhiko Sugimura
Journal:  EMBO J       Date:  2004-02-26       Impact factor: 11.598

3.  EphA2/Ephrin-A1 signaling complexes restrict corneal epithelial cell migration.

Authors:  Nihal Kaplan; Anees Fatima; Han Peng; Paul J Bryar; Robert M Lavker; Spiro Getsios
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-23       Impact factor: 4.799

4.  EPH-EPHRIN in human gastrointestinal cancers.

Authors:  Haruhiko Sugimura; Jian-Dong Wang; Hiroki Mori; Masaru Tsuboi; Kiyoko Nagura; Hisaki Igarashi; Hong Tao; Ritsuko Nakamura; Hiroko Natsume; Tomoaki Kahyo; Kazuya Shinmura; Hiroyuki Konno; Yasushi Hamaya; Shigeru Kanaoka; Hideki Kataoka; Xiao-Jun Zhou
Journal:  World J Gastrointest Oncol       Date:  2010-12-15

Review 5.  Eph/ephrin signaling in epidermal differentiation and disease.

Authors:  Samantha Lin; Bingcheng Wang; Spiro Getsios
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

6.  Activation of EphA receptors mediates the recruitment of the adaptor protein Slap, contributing to the downregulation of N-methyl-D-aspartate receptors.

Authors:  Sophia Semerdjieva; Hayder H Abdul-Razak; Sharifah S Salim; Rafael J Yáñez-Muñoz; Philip E Chen; Victor Tarabykin; Pavlos Alifragis
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

Review 7.  The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.

Authors:  Jill Wykosky; Waldemar Debinski
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

8.  Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.

Authors:  Wei Bin Fang; Dana M Brantley-Sieders; Yoonha Hwang; Amy-Joan L Ham; Jin Chen
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

9.  EphA2 up-regulation induced by deoxycholic acid in human colon carcinoma cells, an involvement of extracellular signal-regulated kinase and p53-independence.

Authors:  Zhongyou Li; Masamitsu Tanaka; Hideki Kataoka; Ritsuko Nakamura; Ravshanov Sanjar; Kazuya Shinmura; Haruhiko Sugimura
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-15       Impact factor: 4.553

10.  The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.

Authors:  Dana M Brantley-Sieders; Guanglei Zhuang; Donna Hicks; Wei Bin Fang; Yoonha Hwang; Justin M M Cates; Karen Coffman; Dowdy Jackson; Elizabeth Bruckheimer; Rebecca S Muraoka-Cook; Jin Chen
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.